Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies.

Tworoger SS, Gates MA, Lee IM, Buring JE, Titus-Ernstoff L, Cramer D, Hankinson SE.

Cancer Res. 2009 Mar 1;69(5):1885-91. doi: 10.1158/0008-5472.CAN-08-3515. Epub 2009 Feb 17. Erratum in: Cancer Res. 2009 Jun 15;69(12):5267. Gate, Margaret A [corrected to Gates, Margaret A].

2.

Associations between polymorphisms in the vitamin D receptor and breast cancer risk.

Chen WY, Bertone-Johnson ER, Hunter DJ, Willett WC, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2335-9.

3.

A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.

Li H, Stampfer MJ, Hollis JB, Mucci LA, Gaziano JM, Hunter D, Giovannucci EL, Ma J.

PLoS Med. 2007 Mar;4(3):e103.

4.

The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature.

Köstner K, Denzer N, Müller CS, Klein R, Tilgen W, Reichrath J.

Anticancer Res. 2009 Sep;29(9):3511-36. Review.

5.

Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk.

Mikhak B, Hunter DJ, Spiegelman D, Platz EA, Hollis BW, Giovannucci E.

Prostate. 2007 Jun 15;67(9):911-23.

PMID:
17440943
6.

Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk.

Lurie G, Wilkens LR, Thompson PJ, McDuffie KE, Carney ME, Terada KY, Goodman MT.

Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2566-71.

7.

Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis.

Tang C, Chen N, Wu M, Yuan H, Du Y.

Breast Cancer Res Treat. 2009 Sep;117(2):391-9. doi: 10.1007/s10549-008-0262-4. Epub 2009 Jan 6.

PMID:
19145484
8.

Vitamin D receptor gene BsmI and FokI polymorphisms in relation to ovarian cancer risk in the Polish population.

Mostowska A, Sajdak S, Pawlik P, Lianeri M, Jagodzinski PP.

Genet Test Mol Biomarkers. 2013 Mar;17(3):183-7. doi: 10.1089/gtmb.2012.0332. Epub 2013 Jan 15.

9.

Vitamin D receptor polymorphisms (FokI, BsmI) and breast cancer risk: association replication in two case-control studies within French Canadian population.

Sinotte M, Rousseau F, Ayotte P, Dewailly E, Diorio C, Giguère Y, Bérubé S, Brisson J.

Endocr Relat Cancer. 2008 Dec;15(4):975-83. doi: 10.1677/ERC-08-0056. Epub 2008 Aug 21.

10.

Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

McKay JD, McCullough ML, Ziegler RG, Kraft P, Saltzman BS, Riboli E, Barricarte A, Berg CD, Bergland G, Bingham S, Brustad M, Bueno-de-Mesquita HB, Burdette L, Buring J, Calle EE, Chanock SJ, Clavel-Chapelon F, Cox DG, Dossus L, Feigelson HS, Haiman CA, Hankinson SE, Hoover RN, Hunter DJ, Husing A, Kaaks R, Kolonel LN, Le Marchand L, Linseisen J, McCarty CA, Overvad K, Panico S, Purdue MP, Stram DO, Stevens VL, Trichopoulos D, Willett WC, Yuenger J, Thun MJ.

Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):297-305. doi: 10.1158/1055-9965.EPI-08-0539.

11.

Vitamin D receptor polymorphisms and cancer.

Gandini S, Gnagnarella P, Serrano D, Pasquali E, Raimondi S.

Adv Exp Med Biol. 2014;810:69-105. Review.

PMID:
25207361
12.

Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women.

Grant DJ, Hoyo C, Akushevich L, Iversen ES, Whitaker R, Marks J, Berchuck A, Schildkraut JM.

Gynecol Oncol. 2013 Apr;129(1):173-8. doi: 10.1016/j.ygyno.2012.12.027. Epub 2012 Dec 21.

13.

Vitamin D receptor Cdx-2 polymorphism and premenopausal breast cancer risk in southern Pakistani patients.

Iqbal Mu, Khan TA, Maqbool SA.

PLoS One. 2015 Mar 23;10(3):e0122657. doi: 10.1371/journal.pone.0122657. eCollection 2015.

14.

Sunlight, polymorphisms of vitamin D-related genes and risk of breast cancer.

Fuhrman BJ, Freedman DM, Bhatti P, Doody MM, Fu YP, Chang SC, Linet MS, Sigurdson AJ.

Anticancer Res. 2013 Feb;33(2):543-51.

15.

Association of vitamin D receptor gene polymorphisms with polycystic ovary syndrome among Indian women.

Dasgupta S, Dutta J, Annamaneni S, Kudugunti N, Battini MR.

Indian J Med Res. 2015 Sep;142(3):276-85. doi: 10.4103/0971-5916.166587.

16.

Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study.

McCullough ML, Stevens VL, Diver WR, Feigelson HS, Rodriguez C, Bostick RM, Thun MJ, Calle EE.

Breast Cancer Res. 2007;9(1):R9.

17.

Vitamin D Receptor Polymorphism and Breast Cancer Risk: A Meta-Analysis.

Lu D, Jing L, Zhang S.

Medicine (Baltimore). 2016 May;95(18):e3535. doi: 10.1097/MD.0000000000003535.

18.

Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data.

Randerson-Moor JA, Taylor JC, Elliott F, Chang YM, Beswick S, Kukalizch K, Affleck P, Leake S, Haynes S, Karpavicius B, Marsden J, Gerry E, Bale L, Bertram C, Field H, Barth JH, Silva Idos S, Swerdlow A, Kanetsky PA, Barrett JH, Bishop DT, Bishop JA.

Eur J Cancer. 2009 Dec;45(18):3271-81. doi: 10.1016/j.ejca.2009.06.011. Epub 2009 Jul 15.

19.

Haplotype analysis of common vitamin D receptor variants and colon and rectal cancers.

Sweeney C, Curtin K, Murtaugh MA, Caan BJ, Potter JD, Slattery ML.

Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):744-9.

20.

Supplemental Content

Support Center